The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers
(Q80081696)
scientific article published on 08 August 2006
scientific article published on 08 August 2006
Language:
other details
description | scientific article published on 08 August 2006 |
External Links
(P356) |
10.1007/S10549-006-9307-8
|
(P698) |
16897431
|
(P6179) |
1040174404
|